Journal
/
Cancer Research
/
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
JoVE Journal
Cancer Research
This content is Free Access.
JoVE Journal Cancer Research
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

English

Automatically Generated

4,831 Views

•

06:25 min

•

June 14, 2021

DOI:

10.3791/62668-v

DOI:
10.3791/62668-v

•

06:25 min
June 14, 2021

•

4 Views
, , , , , , ,
1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center,Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine,Fukushima Medical University

Summary

Automatically generated

A highly accurate in vitro high-throughput assay system was developed to evaluate anticancer drugs using patient-derived tumor organoids (PDOs), similar to cancer tissues but are unsuitable for in vitro high-throughput assay systems with 96-well and 384-well plates.

Explore More Videos

Patient-derived Tumor OrganoidsHigh-throughput In Vitro AssayCell Analysis2D Culture3D CultureMolecular Targeted DrugsCell Suspension384-well MicroplateLiquid HandlerCell Fragmentation And Dispersion Instrument

Read Article

Cite this Article

Higa, A., Takahashi, N., Hiyama, G., Tamura, H., Hoshi, H., Shimomura, K., Watanabe, S., Takagi, M. High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids. J. Vis. Exp. (172), e62668, doi:10.3791/62668 (2021).

Download .ris file

Copy

Share Video

.

Copy